All applicant organizations and/or active award recipients for PAR-24-272 Clinical and Translational Science Award (UM1 Clinical Trial Optional) are eligible to apply for Specialized Innovation Programs (SIPs) under this NOFO. Only the primary UM1 CTSA program hub organization is eligible to apply (not partner or collaborator institutions).Companion optional applications may be submitted under the following scenarios:-concurrently with the UM1-while the UM1 application is under review consideration-after the UM1 application is funded-while the UM1 is under consideration for fundingApplications will only be awarded if there is an awarded UM1 application from the applicant organization.Other information on eligibility and number of applications:An active (not in an extension period) UM1 hub institution can submit up to two applications for SIPs per cycle as the primary institution.A CTSA UM1 hub may have up to two SIPs awards as the primary recipient at a given time.No more than two applications may be submitted by a UM1 hub as a primary per application due date and no more than two applications may be awarded to an active (not in an extension period) CTSA UM1 hub as a primary recipient, at a given time.A UM1 hub that is in an extension period is not allowed to submit an application as the primary institution unless a pending UM1 application has been submitted or is under review or funding consideration. Resubmission of a application without the required UM1 application is only allowed if the companion UM1 application is awarded.For the purpose of this NOFO, SIPs awarded in an extension period count towards the maximum of two SIP awards that may be awarded to an active UM1 hub as a primary, at a given time.

CTSA Program Branch, Division of Clinical Innovation 301-827-2017